MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6601-97-105$20.00
Mol Pharmacol 66:97-105, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gay, E. A.
Right arrow Articles by Mailman, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gay, E. A.
Right arrow Articles by Mailman, R. B.

Functional Selectivity of D2 Receptor Ligands in a Chinese Hamster Ovary hD2L Cell Line: Evidence for Induction of Ligand-Specific Receptor States

Elaine A. Gay, Jonathan D. Urban, David E. Nichols, Gerry S. Oxford, and Richard B. Mailman

Departments of Psychiatry (R.B.M.), Pharmacology (R.B.M.), Cellular and Molecular Physiology (G.S.O.), Neuroscience Center (G.S.O., R.B.M.), the Curriculum in Neurobiology (E.A.G.), and the Curriculum in Toxicology (J.D.U.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and Departments of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana (D.E.N.)

There are now several examples of single G protein-coupled receptors to which binding of specific agonists causes differential effects on the associated signaling pathways. The dopamine D2 receptor is of special importance because the selective activation of functional pathways has been shown both in vitro and in situ. For this reason, the present work characterized a series of rigid D2 agonists in Chinese hamster ovary cells transfected with the human D2L receptor using three distinct functional endpoints: inhibition of cAMP synthesis, stimulation of mitogen-activated protein (MAP) kinase phosphorylation, and activation of G protein-coupled inwardly rectifying potassium channels (GIRKs). In this system, S-propylnorapomorphine (SNPA), R-propylnorapomorphine (RNPA), dihydrexidine (DHX), dinapsoline (DNS), and dinoxyline (DNX) all inhibited forskolin-stimulated adenylate cyclase activity to the same extent as the prototypical D2 agonist quinpirole (QP). The rank order of potency was the following: RNPA >> QP = DNX > SNPA > DHX = DNS. For MAP kinase phosphorylation, DHX, DNS, DNX, and RNPA had efficacy similar to QP, whereas SNPA was a partial agonist. The rank order of potency for MAP kinase phosphorylation was RNPA >> QP = DNX > DHX > DNS = SNPA. DNX activated GIRK channels to the same extent as QP, whereas DHX and DNS were partial agonists, and RNPA and SNPA caused no appreciable activation. These findings indicate that DHX, DNS, RNPA, and SNPA have atypical functional properties at the hD2L receptor and display different patterns of functional selectivity. We hypothesize that this functional selectivity may be a result of ligand induction of specific conformations of the D2L receptor that activate only selected signaling pathways.


Received October 10, 2003; accepted March 24, 2004

Address correspondence to: Dr. Richard B. Mailman, CB #7160, Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7160. E-mail: Richard_Mailman{at}med.unc.edu




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. S. Tutor, P. Penela, and F. Mayor Jr.
Anti-{beta}1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells
Cardiovasc Res, October 1, 2007; 76(1): 51 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-L. Lu, M. Coetsee, C. D. White, and R. P. Millar
Structural Determinants for Ligand-Receptor Conformational Selection in a Peptide G Protein-coupled Receptor
J. Biol. Chem., June 15, 2007; 282(24): 17921 - 17929.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. R. Moya, K. A. Berg, M. A. Gutierrez-Hernandez, P. Saez-Briones, M. Reyes-Parada, B. K. Cassels, and W. P. Clarke
Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1054 - 1061.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. Urban, W. P. Clarke, M. von Zastrow, D. E. Nichols, B. Kobilka, H. Weinstein, J. A. Javitch, B. L. Roth, A. Christopoulos, P. M. Sexton, et al.
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Simmons
Functional Selectivity of NK1 Receptor Signaling: Peptide Agonists Can Preferentially Produce Receptor Activation or Desensitization
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 907 - 913.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Galandrin and M. Bouvier
Distinct Signaling Profiles of beta1 and beta2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy
Mol. Pharmacol., November 1, 2006; 70(5): 1575 - 1584.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-X. Xie, P. Ghorai, Q.-Z. Ye, A. Buschauer, and R. Seifert
Probing Ligand-Specific Histamine H1- and H2-Receptor Conformations with NG-Acylated Imidazolylpropylguanidines
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Mathiesen, T. Ulven, L. Martini, L. O. Gerlach, A. Heinemann, and E. Kostenis
Identification of Indole Derivatives Exclusively Interfering with a G Protein-Independent Signaling Pathway of the Prostaglandin D2 Receptor CRTH2
Mol. Pharmacol., August 1, 2005; 68(2): 393 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. McLaughlin, L. Shen, M. Holinstat, J. D. Brooks, E. DiBenedetto, and H. E. Hamm
Functional Selectivity of G Protein Signaling by Agonist Peptides and Thrombin for the Protease-activated Receptor-1
J. Biol. Chem., July 1, 2005; 280(26): 25048 - 25059.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics